Literature DB >> 25965740

Lilly pays $50 million for Korean BTK.

Allison Proffitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25965740     DOI： 10.1038/nbt0515-440a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Imbruvica--next big drug in B-cell cancer--approved by FDA.

Authors:  Malini Guha
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.